IL10 and myeloid sarcoma: In MS, IL-10 production in blood lymphocytes inversely correlates with lesion load and clinical disability and IL-10 serum levels showed to be a risk factor for further relapses in patients with clinically isolated syndrome (Petereit et al. 2003; Wei et al. 2019).